DETECTION OF HCV RNA IN SUBJECTS WITH ANTIBODY TO HEPATITIS-C VIRUS AMONG THE GENERAL-POPULATION OF FUKUOKA, JAPAN

被引:32
作者
HAYASHI, J
NAKASHIMA, K
YOSHIMURA, E
HIRATA, M
MAEDA, Y
KASHIWAGI, S
机构
[1] The Department of General Medicine, Kyushu University Hospital, Fukuoka, 812, Higashi-ku
[2] Fukuoka Red Cross Blood Center, Chikushino, 818, Kamikoga
关键词
HCV RNA; ANTI-HCV; GENERAL POPULATION;
D O I
10.1007/BF02358675
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Volunteer blood donors and aged people who came to hospitals for a thorough physical checkup were surveyed to evaluated the exact prevalence of hepatitis C virus (HCV) infection in the general population of Fukuoka, Japan. We tested for antibody to HCV (anti-HCV) by second-generation assay and, to distinguish active HCV infection from past resolved infection, we tested for HCV RNA in reactive serum samples by polymerase chain reaction. The prevalence of anti-HCV was 286 (2.0%) of 14341 subjects, increasing with advancing age, from 0.4% in the under-29 age group to 12.0% in the over-70 age group. There were no differences between sexes. HCV RNA was detected in 170 of 286 (59.4%) anti-HCV-positive subjects. The ratio of HCV RNA-positive to anti-HCV-positive subjects was higher in males than in females (P<0.05) and decreased with advancing age, from 72.2% to 46.5%. The prevalence of elevated alanine aminotransferase (ALT) was only 15.9% in subjects with HCV RNA, higher in males (21.4%) than in females (8.3%) (P<0.05). This study revealed that the prevalence of anti-HCV was high in the aged population, but that the ratio of HCV RNA-positive to anti-HCV-positive subjects was low, and most of the HCV RNA-positive subjects had normal ALT levels. © 1994 Springer-Verlag.
引用
收藏
页码:147 / 151
页数:5
相关论文
共 21 条
  • [1] Choo Q-L, Kuo G., Weiner A.J., Et al., Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome, Science, 244, pp. 359-362, (1989)
  • [2] Kao G., Choo Q-L, Alter H.J., Et al., An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis, Science, 244, pp. 362-364, (1989)
  • [3] Watanabe J., Minegishi K., Mitsumori T., Et al., Prevalence of anti-HCV antibody in blood donors in the Tokyo area, Vox Sang, 59, pp. 86-88, (1990)
  • [4] Janot C., Courouce A.M., Maneiz M., Antibodies to hepatitis C virus in French blood donors, Lancet, 2, pp. 796-797, (1989)
  • [5] Shirchia G., Bellobuono A., Giovanetti A., Et al., Antibodies to hepatitis C virus in Italian blood donors, Lancet, 2, (1989)
  • [6] Kuhnl P., Seidl S., Stangel W., Et al., Antibody to hepatitis C virus in German blood donors, Lancet, 2, (1989)
  • [7] Stevens C.E., Taylor P.E., Pindyck J., Et al., Epidemiology of hepatitis C virus: A preliminary study in volunteer blood donors, JAMA, 263, pp. 49-53, (1990)
  • [8] Mishiro S., Hoshi Y., Takeda K., Et al., Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: Implication for an autoimmune process, Lancet, 336, pp. 1400-1403, (1990)
  • [9] Van der Poel C.L., Cuypers H.T.M., Reesink H.W., Et al., Confirmation of hepatitis C virus infection by new four-antigen recombinant blot assay, Lancet, 337, pp. 317-319, (1991)
  • [10] Marcellin P., Martinot-Peignoux M., Boyer N., Et al., Second generation (RIBA) test in diagnosis of chronic hepatitis C, Lancet, 337, pp. 551-552, (1991)